← FDA DRUG APPROVALS
FDA ANDA · ANDA203767
TRAVOPROST OPHTHALMIC
travoprost ophthalmic solution
Sponsor: MICRO LABS
APPLICATION
ANDA203767
TYPE
ANDA
ORIGINAL APPROVAL
2021-03-19
LATEST ACTION
2021-03-19
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TRAVOPROSTPrescription
TRAVOPROST 0.004% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2021-03-19UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.